UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

Empirical pathological staging and subtyping of TDP‐43 proteinopathies

Alzheimer's & dementia, 2022-12, Vol.18 (S4), p.n/a

2022

Volltextzugriff (PDF)

Regional distribution of tau pathology in subfields of hippocampus among phenotypic variants of AD and FTLD‐tau

Alzheimer's & dementia, 2021-12, Vol.17, p.e052392-n/a

2021

Volltextzugriff (PDF)

Genetic Drivers of Atypical Alzheimer’s Disease Neuropathologic Change

Alzheimer's & dementia, 2023-12, Vol.19 (S12), p.n/a

Lee, Eddie B

2023

Volltextzugriff (PDF)

Transcriptomic signatures of regional selective vulnerability in ALS and FTLD‐TDP

Alzheimer's & dementia, 2023-12, Vol.19 (S12), p.n/a

2023

Volltextzugriff (PDF)

Short Telomeres Associate with Hyperphosphorylated Tau Burden in Primary Age‐Related Tauopathy

Alzheimer's & dementia, 2022-12, Vol.18 (S3), p.n/a

2022

Volltextzugriff (PDF)

Shared and disparate transcriptomic signatures associated with cortical atrophy change in genetic behavioral variant frontotemporal degeneration

Alzheimer's & dementia, 2023-12, Vol.19 (S12), p.n/a

2023

Volltextzugriff (PDF)

Modules of genotypic variance reflect heterogeneity across TDP‐43 proteinopathies

Alzheimer's & dementia, 2022-12, Vol.18 (S4), p.n/a

2022

Volltextzugriff (PDF)

Plasma GFAP:NfL discriminates FTLD‐tau from FTLD‐TDP

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

Pyramidal neurodegeneration is linked to select cytoarchitecture and cognitive impairment in behavioral variant frontotemporal dementia with tau or TDP‐43 pathology

Alzheimer's & dementia, 2023-12, Vol.19 (S12), p.n/a

2023

Volltextzugriff (PDF)

Plasma glial fibrillary acidic protein is associated with concomitant brain β‐amyloid in Lewy body disease

Alzheimer's & dementia, 2023-12, Vol.19 (S15), p.n/a

2023

Volltextzugriff (PDF)

Quantifying associations of four major proteinopathies with grey matter atrophy: an imaging‐pathology study

Alzheimer's & dementia, 2023-12, Vol.19 (S17), p.n/a

2023

Volltextzugriff (PDF)

Quantifying associations of four major proteinopathies with grey matter atrophy: an imaging‐pathology study

Alzheimer's & dementia, 2023-12, Vol.19 (S10), p.n/a

2023

Volltextzugriff (PDF)

Automatic analysis and validation of digitized speech markers in Lewy body spectrum diseases with Alzheimer’s disease co‐pathology

Alzheimer's & dementia, 2021-12, Vol.17 (S4), p.n/a

2021

Volltextzugriff (PDF)

Cerebrospinal fluid neurogranin in non‐amnestic and amnestic Alzheimer’s disease

Alzheimer's & dementia, 2021-12, Vol.17 (S5), p.n/a

2021

Volltextzugriff (PDF)

Characterizing Amyloid Responsive Microglia in a Cognitively Resilient Patient with Alzheimer’s Disease Neuropathologic Change: A Case Report

Alzheimer's & dementia, 2022-12, Vol.18 (S3), p.n/a

2022

Volltextzugriff (PDF)

Tau maturation in clinicopathological spectrum of Lewy body and Alzheimer’s disease

Alzheimer's & dementia, 2023-12, Vol.19 (S12), p.n/a

2023

Volltextzugriff (PDF)

Evaluation of quantitative measurements of tau pathology with semi‐quantitative ratings and age

Alzheimer's & dementia, 2023-12, Vol.19 (S10), p.n/a

2023

Volltextzugriff (PDF)

Evaluation of quantitative measurements of tau pathology with semi‐quantitative ratings and age

Alzheimer's & dementia, 2023-12, Vol.19 (S14), p.n/a

2023

Volltextzugriff (PDF)

Epigenetic measurement of biological age associates with tau load in normal brain aging: Neuroimaging / Normal brain aging

Alzheimer's & dementia, 2020-12, Vol.16 (S5)

2020

Volltextzugriff (PDF)

Lower neocortical tau burden distinguishes Alzheimer’s pathology occurring with vs. without primary non‐Alzheimer’s pathology

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Preferential degeneration of the locus coeruleus in tauopathies relative to TDP‐43 proteinopathies: Human neuropathology/selective vulnerability

Alzheimer's & dementia, 2020-12, Vol.16 (S2)

2020

Volltextzugriff (PDF)

Lower neocortical tau burden distinguishes Alzheimer’s pathology occurring with vs. without primary non‐Alzheimer’s pathology: Biomarkers (non‐neuroimaging) / Differential diagnosis

Alzheimer's & dementia, 2020-12, Vol.16 (S5)

2020

Volltextzugriff (PDF)

Epigenetic measurement of biological age associates with tau load in normal brain aging

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Preferential degeneration of the locus coeruleus in tauopathies relative to TDP‐43 proteinopathies

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Tau‐Neurodegeneration mismatch reveals vulnerability and resilience in Alzheimer’s continuum and Non‐Alzheimer’s pathophysiology

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Empirical pathological staging and subtyping of TDP‐43 proteinopathies

Regional distribution of tau pathology in subfields of hippocampus among phenotypic variants of AD and FTLD‐tau

Genetic Drivers of Atypical Alzheimer’s Disease Neuropathologic Change

Transcriptomic signatures of regional selective vulnerability in ALS and FTLD‐TDP

Short Telomeres Associate with Hyperphosphorylated Tau Burden in Primary Age‐Related Tauopathy

Shared and disparate transcriptomic signatures associated with cortical atrophy change in genetic behavioral variant frontotemporal degeneration

Modules of genotypic variance reflect heterogeneity across TDP‐43 proteinopathies

Plasma GFAP:NfL discriminates FTLD‐tau from FTLD‐TDP

Pyramidal neurodegeneration is linked to select cytoarchitecture and cognitive impairment in behavioral variant frontotemporal dementia with tau or TDP‐43 pathology

Plasma glial fibrillary acidic protein is associated with concomitant brain β‐amyloid in Lewy body disease

Quantifying associations of four major proteinopathies with grey matter atrophy: an imaging‐pathology study

Quantifying associations of four major proteinopathies with grey matter atrophy: an imaging‐pathology study

Automatic analysis and validation of digitized speech markers in Lewy body spectrum diseases with Alzheimer’s disease co‐pathology

Cerebrospinal fluid neurogranin in non‐amnestic and amnestic Alzheimer’s disease

Characterizing Amyloid Responsive Microglia in a Cognitively Resilient Patient with Alzheimer’s Disease Neuropathologic Change: A Case Report

Tau maturation in clinicopathological spectrum of Lewy body and Alzheimer’s disease

Evaluation of quantitative measurements of tau pathology with semi‐quantitative ratings and age

Evaluation of quantitative measurements of tau pathology with semi‐quantitative ratings and age

Epigenetic measurement of biological age associates with tau load in normal brain aging: Neuroimaging / Normal brain aging

Lower neocortical tau burden distinguishes Alzheimer’s pathology occurring with vs. without primary non‐Alzheimer’s pathology

Preferential degeneration of the locus coeruleus in tauopathies relative to TDP‐43 proteinopathies: Human neuropathology/selective vulnerability

Lower neocortical tau burden distinguishes Alzheimer’s pathology occurring with vs. without primary non‐Alzheimer’s pathology: Biomarkers (non‐neuroimaging) / Differential diagnosis

Epigenetic measurement of biological age associates with tau load in normal brain aging

Preferential degeneration of the locus coeruleus in tauopathies relative to TDP‐43 proteinopathies

Tau‐Neurodegeneration mismatch reveals vulnerability and resilience in Alzheimer’s continuum and Non‐Alzheimer’s pathophysiology

Suchergebnisse filtern